Immunovant (IMVT)
(Real Time Quote from BATS)
$30.98 USD
+0.47 (1.54%)
Updated Jul 16, 2024 03:12 PM ET
4-Sell of 5 4
D Value D Growth C Momentum F VGM
Brokerage Reports
0 items in cart
Immunovant, Inc. [IMVT]
Reports for Purchase
Showing records 101 - 105 ( 105 total )
Company: Immunovant, Inc.
Industry: Medical - Biomedical and Genetics
No Power, No Problem, as IMVT-1401 Hits Stat Sig in MG Trial; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Immunovant, Inc.
Industry: Medical - Biomedical and Genetics
First Quarter Financial Update for Immunovant; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Immunovant, Inc.
Industry: Medical - Biomedical and Genetics
Company: Immunovant, Inc.
Industry: Medical - Biomedical and Genetics
SC Formulation Should Secure a Place in the Blockbuster FcRn Space; Initiate With Buy and $34 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Immunovant, Inc.
Industry: Medical - Biomedical and Genetics
KOL Perspectives on FcRn''s for the Treatment of Myasthenia Gravis
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D